About: Randomized, Open-Label, Phase IV, Korean Study of Kidney Transplant Patients Converting From Cyclosporine to Prolonged-Release Tacrolimus Plus Standard- or Reduced-Dose Corticosteroids

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Randomized, Open-Label, Phase IV, Korean Study of Kidney Transplant Patients Converting From Cyclosporine to Prolonged-Release Tacrolimus Plus Standard- or Reduced-Dose Corticosteroids Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 26 January 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu en xineru de 2019 (ast) im Januar 2019 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 26 January 2019 (en) наукова стаття, опублікована 26 січня 2019 (uk)
publication date	wds:Q93063069-A2D7F569-42BE-448A-B6FF-ACFCD915A1C1
publication date	2019-01-26 00:00:00Z (xsd:dateTime)
cites work	wds:Q93063069-01674395-F2ED-4129-897C-077CB37AB74A wds:Q93063069-11291FBA-E024-48C4-9D5E-59DC75395232 wds:Q93063069-16E62AB1-27A4-468F-A67A-60E67AA9CF0D wds:Q93063069-2E540945-1008-422F-9444-2D3EDF656E52 wds:Q93063069-31A9B271-1DC6-456E-8A39-200F06E4390D wds:Q93063069-32212FE3-E407-415C-8F2A-CA4133CDC0EF wds:Q93063069-61887607-FB32-4B6F-BA07-577B70C22488 wds:Q93063069-6340BBB9-5E97-4F8D-BE0F-01A9DED55EC8 wds:Q93063069-66498E57-8DAD-421D-A2B5-C16244EC1B93 wds:Q93063069-69E6F9EA-C530-4E91-8947-19C57B9BAE97 wds:Q93063069-6F2DC6F9-4464-4E15-A2AC-04E0846D8DE0 wds:Q93063069-6F4A3D1C-0269-4418-929A-62EBEEDB6016 wds:Q93063069-7FAB2376-0ADD-4597-900E-FE48364CCA0E wds:Q93063069-86430D8C-DAC2-4671-9A06-D700B5E5EB21 wds:Q93063069-8FA93656-AC72-47E5-A895-2238EE49B44A wds:Q93063069-9641D041-BC25-4738-9826-BF5B1ED4AD3D wds:Q93063069-A0F37DF2-BF38-4DDD-BBB3-EC4A5A624DD7 wds:Q93063069-BB610274-DA20-413B-929D-62AAE568B87D wds:Q93063069-C38F1751-D360-432D-93F3-C144C5C357EE wds:Q93063069-C8DCC436-7AA3-4C81-A38E-B67A51798BE3 wds:Q93063069-CFCD4EA4-3224-49D1-A185-05B3BA7CC691 wds:Q93063069-D30CCDD7-45A0-47C5-97A5-F4026FC7599F wds:Q93063069-D7304F56-1CD5-4B12-A0E9-E89A2380D26E wds:Q93063069-D9B51D17-5228-48D5-AFC5-1EE1CA650F2F wds:Q93063069-F158338E-86E2-4817-9CAC-8DA45E713539
cites work	Banff 07 classification of renal allograft pathology: updates and future directions Reduced exposure to calcineurin inhibitors in renal transplantation Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence Incidence and long-term cost of steroid-related side effects after renal transplantation Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients Improved Adherence to Tacrolimus Once-Daily Formulation in Renal Recipients Advagraf(®) , a once-daily prolonged release tacrolimus formulation, in kidney transplantation: literature review and guidelines from a panel of experts Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody. Long-term graft survival with neoral and tacrolimus: a paired kidney analysis High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation Long-term follow-up of a phase III clinical trial comparing tacrolimus extended-release/MMF, tacrolimus/MMF, and cyclosporine/MMF in de novo kidney transplant recipients Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study. Graft failure due to noncompliance among 628 kidney transplant recipients with long-term follow-up: a single-center observational study Immunosuppressant treatment adherence, barriers to adherence and quality of life in renal and liver transplant recipients in Spain OPTN/SRTR 2015 Annual Data Report: Kidney Treatment adherence in renal transplant recipients: a questionnaire survey on immunosuppressants Conversion to tacrolimus once-daily from ciclosporin in stable kidney transplant recipients: a multicenter study
author name string	wds:Q93063069-01893B3D-412F-4065-8732-D2CB08634041 wds:Q93063069-0505D318-E1F1-4921-93E3-27EC4944C832 wds:Q93063069-240B9964-85FE-46D3-BFD0-26AD33A06C1C wds:Q93063069-270CDC64-70E2-43CE-82E4-96CD63E0CD33 wds:Q93063069-4275316A-4786-47ED-8BBE-E87B4242CBFB wds:Q93063069-5B03C83E-AE98-43E5-9424-679C3D7AD8F6 wds:Q93063069-62397DB0-483C-4BC8-8065-2FAE87879C2D wds:Q93063069-6811F2FE-1829-4B68-A1B8-459141285BC1 wds:Q93063069-6973153A-438F-4E9C-A2C6-A3D15B1BB5D9 wds:Q93063069-7111DAC7-E819-4FE3-BDF6-36C0E7425E93 wds:Q93063069-8045CD41-911B-49AD-94AD-62CD50D62136 wds:Q93063069-93047349-54AF-4FF2-AEB6-6471D8524ACD wds:Q93063069-AC2F8A76-5E14-4F0D-BB88-0E57B96B9013 wds:Q93063069-AFBA8B56-DF8C-45AF-9492-804D23BC8EDA wds:Q93063069-C85BA70C-1578-43DB-B888-8AA6A5E352B1 wds:Q93063069-CDE18608-05E2-4DA8-82A0-DBAA942EE73D wds:Q93063069-E9F191E1-2841-48A3-AA1D-BAFAF0260B3A wds:Q93063069-F4B45733-0586-4737-930D-959A031D811F wds:Q93063069-F651BE68-3DBC-493F-AD1A-499EACC95A6F
author name string	J Yang H Lee Y H Kim H Jiang J S Lee S W Kim S H Lee S Lee K W Lee S Y Han B S Kim Y J Kwon C-D Kim D W Chae D R Lee B C Shin C H Baek S-K Park J M Kong
rdfs:label	Randomized, Open-Label, Phase IV, Korean Study of Kidney Transplant Patients Converting From Cyclosporine to Prolonged-Release Tacrolimus Plus Standard- or Reduced-Dose Corticosteroids (en) Randomized, Open-Label, Phase IV, Korean Study of Kidney Transplant Patients Converting From Cyclosporine to Prolonged-Release Tacrolimus Plus Standard- or Reduced-Dose Corticosteroids (nl)
skos:prefLabel	Randomized, Open-Label, Phase IV, Korean Study of Kidney Transplant Patients Converting From Cyclosporine to Prolonged-Release Tacrolimus Plus Standard- or Reduced-Dose Corticosteroids (en) Randomized, Open-Label, Phase IV, Korean Study of Kidney Transplant Patients Converting From Cyclosporine to Prolonged-Release Tacrolimus Plus Standard- or Reduced-Dose Corticosteroids (nl)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software